REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 134 filers reported holding REPLIMUNE GROUP INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $204,680 | -48.1% | 7,525 | -67.0% | 0.00% | -50.0% |
| Q3 2022 | $394,000 | -1.3% | 22,800 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $399,000 | +3.1% | 22,800 | 0.0% | 0.01% | +16.7% |
| Q1 2022 | $387,000 | -37.4% | 22,800 | 0.0% | 0.01% | -33.3% |
| Q4 2021 | $618,000 | -8.6% | 22,800 | 0.0% | 0.01% | -10.0% |
| Q3 2021 | $676,000 | -22.8% | 22,800 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $876,000 | +25.9% | 22,800 | 0.0% | 0.01% | +33.3% |
| Q1 2021 | $696,000 | -20.0% | 22,800 | 0.0% | 0.01% | -25.0% |
| Q4 2020 | $870,000 | -10.9% | 22,800 | -46.2% | 0.01% | -20.0% |
| Q3 2020 | $976,000 | – | 42,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 5,344,971 | $122,395,000 | 33.11% |
| Corriente Advisors, LLC | 512,500 | $11,798,000 | 5.98% |
| Bain Capital Life Sciences Investors, LLC | 2,122,415 | $48,858,000 | 4.55% |
| BVF INC/IL | 1,691,834 | $38,946,000 | 2.12% |
| Redmile Group, LLC | 3,330,999 | $76,680,000 | 1.41% |
| EMERALD ADVISERS, LLC | 891,761 | $20,528,000 | 0.84% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 823,989 | $18,968,000 | 0.84% |
| Penn Mutual Asset Management, LLC | 15,877 | $365,000 | 0.52% |
| EAM Global Investors LLC | 54,274 | $1,249,000 | 0.46% |
| Artal Group S.A. | 700,000 | $16,114,000 | 0.39% |